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Abstract
Objective:  To  determine  the  prevalence  of  symptoms  of  asthma,  rhinitis,  and  atopic  eczema
in adolescents  (AD;  13-14  years)  living  in  seven  Brazilian  cities,  by  applying  the  standardized
written  questionnaire  (WQ)  of  the  International  Study  of  Asthma  and  Allergies  in  ChildhoodAtopic  eczema;
Epidemiology;
Allergic  rhinitis;
(ISAAC),  and  to  evaluate  the  time  trend  nine  years  after  the  last  assessment  of  ISAAC  phase  3
(ISP3).Rhinoconjunctivitis Methods:  The  ISAAC-WQ  was  answered  by  20,099  AD  from  the  Northern,  Northeastern,  South-
eastern, and  Southern  Brazilian  regions.  Values  obtained  were  compared  to  those  observed
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in  ISP3  using  nonparametric  (chi-squared  or  Fisher)  tests,  and  the  ratio  of  annual  incre-
ment/decrement  was  established  for  each  of  the  centers,  according  to  the  symptom  assessed.
Results:  Considering  the  national  data  and  comparing  to  values  of  ISP3,  there  was  a  decrease
in the  mean  prevalence  of  active  asthma  (18.5%  vs.  17.5%)  and  an  increase  in  the  frequency  of
severe  asthma  (4.5%  vs.  4.7%)  and  physician-diagnosed  asthma  (14.3%  vs.  17.6%).  An  increase
in  prevalence  of  rhinitis,  rhinoconjunctivitis,  and  atopic  eczema  was  also  observed.
Conclusions: The  prevalence  of  asthma,  rhinitis,  and  atopic  eczema  in  Brazil  was  variable;
higher prevalence  values,  especially  of  asthma  and  eczema,  were  observed  in  regions  located
closer  to  the  Equator.
© 2014  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
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Prevalência  de  asma  e  doenc¸as  alérgicas  em  adolescentes:  estudo  evolutivo  de  nove
anos  (2003  a  2012)
Resumo
Objetivo:  Determinar  a  prevalência  de  sintomas  relacionados  à  asma,  rinite  e  eczema  atópico
em adolescentes  (13-14  anos,  AD)  residentes  em  sete  cidades  brasileiras  empregando  o  ques-
tionário  escrito  (QE)  padronizado  do  International  Study  of  Asthma  and  Allergies  in  Childhood
(ISAAC)  e  veriﬁcar  a  tendência  temporal  passados  nove  anos  da  última  avaliac¸ão  do  ISAAC  fase
3  (ISF3).
Métodos:  O  QE  ISAAC  foi  respondido  por  20.099  AD  (13-14  anos)  moradores  em  centros  das
regiões Norte,  Nordeste,  Sudeste  e  Sul.  Os  índices  obtidos  foram  comparados  aos  do  ISF3
utilizando-se  teste  não  paramétrico  (qui-quadrado  ou  Fisher)  e  foi  estabelecida  a  taxa  de
incremento/decremento  anual  para  cada  um  dos  centros  segundo  o  sintoma  avaliado.
Resultados: Em  relac¸ão  ao  ISF3,  considerando-se  os  dados  nacionais,  houve  queda  da  prevalên-
cia média  de  asma  ativa  (18,5%  vs.  17,5%)  com  elevac¸ão  da  frequência  de  asma  grave  (4,5%  vs.
4,7%)  e  de  asma  diagnosticada  por  médico  (14,3%  vs.17,6%).  Aumento  da  prevalência  de  rinite
e  rinoconjuntivite  e  de  eczema  ﬂexural  também  ocorreram.
Conclusões:  A  prevalência  de  asma,  rinite  e  eczema  atópico  no  Brasil  foi  variável.  Valores  mais
altos, sobretudo  de  asma  e  eczema  foram  observados  nos  centros  localizados  mais  próximos  ao
Equador.
©  2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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The  prevalence  of  asthma  and  allergic  diseases  in  chil-
dren has  shown  wide  variation  worldwide  and  according
to some  authors,  it  has  increased,  especially  in  developing
countries.1--5 Up  to  a  few  decades  ago  this  knowledge  was
limited, for  lack  of  a  single,  standardized,  and  validated
tool to  be  used  universally,  and  restricted  to  studies  were
performed in  small  samples,  which  precluded  comparisons
between different  populations  and  at  different  times.
After  the  International  Study  of  Asthma  and  Allergies  in
Childhood (ISAAC),  which  created  a  standardized  protocol,
such comparisons  became  possible;  since  then,  have  been
widely performed.6 Before  the  ISAAC  protocol,  few  studies,
using the  same  tool  (written  questionnaire  [WQ]),  were  able
to evaluate  the  temporal  trend  of  the  prevalence  of  asthma,
rhinitis, and  atopic  eczema  in  children.  One  of  these  stud-
ies assessed  Norwegian  children  aged  7  to  14  years  between
1985 and  2008,  regarding  the  prevalence  of  asthma,  rhinitis,
and atopic  eczema;  a  trend  of  increasing  asthma  and  rhini-
tis prevalence  and  stabilization  for  eczema  was  observed.7
Another  study,  with  a  longer  follow-up,  conducted  from
t
m
a
c964  to  2004  in  English  schoolchildren  (7-12  years)  observed
eclining rates  of  wheezing,  with  an  increase  in  rhinocon-
unctivitis and  atopic  eczema.8
The  mean  time  between  the  completion  of  ISAAC  Phase
 (ISF1)  and  ISAAC  Phase  3  (ISF3)  was  seven  years,  and
he prevalence  rates  obtained  in  all  centers  that  con-
urrently participated  in  both  phases  showed  conﬂicting
esults, mainly  in  those  centers  that  presented  high  values.2
n  Brazil,  an  increase  in  the  prevalence  of  asthma  symp-
oms in  schoolchildren  aged  6-7  years  from  21.3%  in  ISF1  to
4.4% in  ISF3  and  a  stable  prevalence  of  rhinoconjunctivi-
is (12.5%  and  12.0%,  respectively)  and  atopic  eczema  (6.8%
nd 6.8%,  respectively)  were  observed.  Among  adolescents
ADs) there  was  a  decrease  in  prevalence  rates  of  asthma
ymptoms (22.7%  to  19.9%,  respectively),  rhinoconjunctivi-
is (16.2%  to  15.8%,  respectively),  and  atopic  eczema  (5.3%
o 4.2%,  respectively).2
At  that  time,  there  was  no  unanimous  explanation  for
he previously  observed  ﬁndings.  This  study  aimed  to  deter-
ine the  variations  in  the  prevalence  of  asthma,  rhinitis,
nd atopic  eczema  in  Brazilian  ADs  nine  years  after  ISF3  was
ompleted.
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ubjects and method
even  of  the  21  centers  participating  in  the  ISF3  in  Brazil2,9--11
ccepted  the  invitation  to  participate  in  this  study,  nine
ears after  its  completion.  The  study  was  supported  by
APESP (Project  PPSUS  No.  2009-53303-5).  The  recom-
ended criteria  were  met  in  all  centers  and  the  ADs  were
elected as  recommended  by  the  ISAAC6,12 protocol.  With
he exception  of  Belém  (state  of  Pará,  North  [N]),  all  other
enters had  their  ISF3  data  approved  by  the  ISAAC  Inter-
ational Data  Center,  and  the  following  were  categorized
s ofﬁcial  centers:  Recife  (Pernambuco,  Northeast  [NE]);
aceió (Alagoas,  NE);  Aracaju  (Sergipe,  NE);  Belo  Horizonte
Minas Gerais,  Southeast  [SE]);  São  Paulo  (São  Paulo,  SE);
nd Curitiba  (Paraná,  South  [S])  (Tables  1  and  2).
In  all  participating  centers,  ADs  (13-14  years  old)  were
elected from  public  and  private  schools.  Data  on  num-
er of  schools  and  students  enrolled  were  provided  by  the
espective Departments  of  Education  of  each  center,  and  a
inimum of  1,000  students  were  assessed.  The  study  was
pproved by  each  Research  Ethics  Committee,  and  all  sub-
ects signed  an  informed  consent;  data  collection  iniciated
n 2011  and  was  completed  in  2012.  The  general  project  was
pproved by  Universidade  Federal  de  São  Paulo/Hospital  São
aulo  Research  Ethics  Committee  (n.  1345/09).
After  deﬁning  the  sample  in  each  of  the  cities,  the
SAAC WQ,  previously  translated  into  Brazilian  Portuguese
nd culturally  validated,13--15 was  completed  by  ADs  in  their
lassrooms (n  =  20,099),  which  yielded  a  high  rate  of  properly
lled out  questionnaires.  Data  were  manually  transferred  to
he database  provided  by  the  general  coordinators  of  ISAAC
rotocol.
From the  ISAAC-WQ  asthma  module,  the  following  ques-
ions were  considered:  wheezing  at  some  time;  wheezing
n the  last  12  months  (current  asthma);  wheezing  severe
nough to  limit  speech  in  the  last  12  months  (severe
sthma); physician-diagnosed  asthma  (asthma  at  some  time
n life);  wheezing  at  exercises;  and  nocturnal  cough.2,13
From  the  ISAAC-WQ  rhinitis  module,  the  following  ques-
ions were  considered:  sneezing,  runny  nose  and  nasal
bstruction at  some  time  in  the  past  12  months  (rhinitis),
nd nasal  problems  associated  with  itchy  and  watery  eyes  in
he last  12  months  (rhinoconjunctivitis).2,14
From  the  ISAAC-WQ  eczema  module,  the  following
uestions were  considered:  skin  rash  that  appeared  and
isappeared in  the  last  12  months  (eczema)  and  this  charac-
eristic rash  in  places  such  as  skinfolds  and  buttocks  (atopic
czema).2,15
The  values  obtained  were  compared  to  those  previously
ublished in  ISF39--11 and  expressed  as  an  annual  percent-
ge of  change  (Table  2).  Data  analysis  was  performed  with
on-parametric tests,  chi-squared  test,  or  Fisher’s  exact  test
nd 5%  was  established  as  the  rejection  level  for  the  null
ypothesis.
esultsable  1  summarizes  the  percentage  data  on  the  prevalence
f symptoms  of  asthma,  rhinitis,  and  eczema  of  ADs  from
even Brazilian  centers  that  participated  in  the  ISF3,  as
ell as  the  current  values,  obtained  nine  years  later.
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omparative  analysis  between  the  values  obtained  in  the
wo studies  was  performed  in  each  center;  signiﬁcantly
igher values  were  identiﬁed.
Considering  the  general  data,  a  signiﬁcant  decrease  was
bserved in  the  prevalence  of  wheezing  at  some  time  in  life,
heezing in  the  previous  year  (active  asthma),  and  wheezing
ssociated with  exercise  during  this  period  (Table  1).  Con-
ersely, there  was  a  signiﬁcant  increase  in  the  prevalence  of
hysician-diagnosed asthma,  nocturnal  cough,  nasal  symp-
oms without  having  a  cold  (rhinitis),  rhinoconjunctivitis,
nd atopic  eczema  (Table  1).  Regarding  the  annual  percent-
ge of  change,  a  decrease  of  0.41%/year  was  observed  for
he prevalence  of  wheezing  at  some  time  in  life  and  an
ncrease of  0.6%/year  for  the  reporting  of  nocturnal  cough
Table 2).  For  nasal  symptoms,  there  was  an  increase  of
.68%/year for  rhinitis  and  0.55%/year  for  rhinoconjunctivi-
is, as  well  as  a  0.08%  annual  increase  for  atopic  eczema
Table 2).
iscussion
hen  the  prevalence  rates  observed  in  different  centers
articipating in  this  study  are  analyzed,  nine  years  after
he end  of  ISF3,  a  distinct  and  variable  behavior  can
e observed.  In  general,  a  decline  in  the  prevalence  of
ctive asthma  and  an  increase  in  the  prevalence  of  rhinitis,
hinoconjunctivitis, as  well  as  atopic  eczema  were  observed
Tables 1  and  2).
Regarding  asthma  and  related  symptoms,  it  was  observed
hat the  decrease  in  the  prevalence  of  active  asthma  was
artly due  to  the  decrease  observed  in  Belém  and  Ara-
aju, despite  the  signiﬁcant  increase  that  occurred  in  São
aulo. Moreover,  there  was  a  signiﬁcant  increase  in  the
revalence of  physician-diagnosed  asthma,  which  ranged
etween 14.3%  and  17.6%  in  all  centers,  except  Belém  and
racaju. Conversely,  the  number  of  severe  events  (speech
mpairment) remained  unchanged,  as  opposed  to  nonspe-
iﬁc symptoms  such  as  nocturnal  cough,  which  increased
Tables 1  and  2).
What happened  during  this  time  interval  that  would
xplain these  changes?  When  analyzing  the  period  of
8 years  since  the  ISF1  data  were  obtained,  it  can  be
bserved that  the  Human  Development  Index  (HDI)  in  Brazil
ncreased, going  from  0.724  in  1993/199416 to  0.807  in
012.17 This  increase  was  observed  in  all  centers  involved
n the  study;  however,  it  was  more  pronounced  in  the  NE
nd N  regions.  There  was  no  signiﬁcant  correlation  between
DI and  the  prevalence  of  active  asthma,  rhinoconjunctivi-
is, and  atopic  eczema  in  both  2003  and  2012  (data  not
hown).
These data  are  corroborated  when  considering  the  fact
hat the  Gross  Domestic  Product  presented  the  same  behav-
or, going  from  US$  3,040  in  1994  to  US$  11,630  in  2012.18,19
lthough  the  country  economic  status  did  improve,  to  infer
hat such  improvement  is  responsible  for  the  changes  in  the
revalence rates  observed  herein  is  a  fragile  assumption.
Moreover,  after  the  2000s,  asthma  treatment  improved,
s the  creation  of  the  National  Asthma  Control  Plan  (Plano
acional de  Controle  da  Asma  -  PNCA)  started  providing  drug
herapy for  patients  with  severe  asthma20 and  was  extended
n 2005  to  patients  with  mild  or  moderate  asthma.21
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Table  1  Prevalence  of  afﬁrmative  responses  to  the  questions  on  symptoms  of  asthma,  rhinitis  and  eczema  of  the  written  questionnaire  of  the  International  Study  of  Asthma
and Allergies  in  Childhood  given  by  adolescent  from  the  centers  that  participated  in  the  ISAAC  phase  3  study  and  in  the  current  study.
Question  Belém  Recifea Maceióa Aracajua
2003  2012  2003  2012  2003  2012  2003  2012
n =  1,773 n  =  3,708 n  =  2,865 n  =  1,149 n  =  2,745 n  =  3,628 n  =  3,041 n  =  3,009
Wheezing  at  some  time 43.1b 38.7 37.8b 32.9 29.5b 25.2 33.2b 25.4
Wheezing  in  12  months 23.1b 20.7 19.1 19.6 14.8 13.2 18.72 12.8
Speech  impairment 5.0 6.0 4.1 7.0b 5.0b 3.5 6.8b 3.6
Asthma  diagnosis 32.8b 29.3 18.0 22.52 13.8 15.8b 15.4b 12.7
Wheezing  at  exercises 21.7 22.5 23.0 22.5 18.9b 14.6 19.0b 16.4
Nocturnal  cough 45.7 51.1b 37.3 41.0b 42.0 40.8 41.3b 38.3
Nasal  symptoms  in  12  months 47.4b 44.2 35.8b 26.3 26.4 38.8b 25.6 29.9b
Rhinoconjunctivitis  28.5 27.9 14.5 17.3b 13.8 19.2b 17.4b 15.4
Skin  symptoms 11.8 12.5 10.1 8.4 7.5 8.9b 11.2b 7.1
Atopic  eczema 6.2 7.9b 5.0 3.9 4.0 5.1b 7.9b 3.4
Question Belo  Horizontea São  Pauloa Curitibaa General
2003  2012  2003  2012  2003  2012  2003  2012
n  =  3,088 n  =  2,642 n =  3,161 n  =  2,433 n  =  3,628 n  =  3,530 n  =  20,301 n  =  20,099
Wheezing  at  some  time  47.3  45.5  44.6  43.7  40.7  39.8  38.8  35.5b
Wheezing  in  12  months  17.8  19.7  18.7  21.3b 18.9  17.6  18.5  17.5b
Speech  impairment  4.8  5.0  2.9  4.4b 3.1  4.5b 4.5  4.7
Asthma  diagnosis  9.8  17.3b 10.4  13.6b 9.2  13.1b 14.3  17.6b
Wheezing  at  exercises  18.6  21.7b 17.0b 12.1  19.1  19.9  19.4  18.3b
Nocturnal  cough  37.4  39.3  33.3  45.4b 34.7  42.4b 38.2  43.0b
Nasal  symptoms  in  12  months  26.1  34.1b 27.4  49.9b 39.2b 31.6  31.8  37.2b
Rhinoconjunctivitis  14.5  18.3b 12.2  24.5b 17.2  18.8  16.2  20.6b
Skin  symptoms  9.1  8.3  12.7b 8.6  6.3  8.8b 9.6  9.1
Atopic  eczema  5.2  5.4  3.6  6.6b 3.7  5.7b 5.0  5.6b
Speech impairment, wheezing so intense that was able to prevent two consecutive words from being said in the last 12 months; Wheezing at exercise, wheezing during exercise in the
past 12 months; Nocturnal cough, coughing at night without having a cold in the last 12 months; Nasal symptoms in 12 months, sneezing, runny nose or nasal stufﬁness at some time in the
last 12 months; Rhinoconjunctivitis, nasal problem with itching and watery eyes in the last 12 months; Skin symptoms, itchy rash that appeared and disappeared in the last 12 months;
Atopic eczema, itchy rash that appeared and disappeared in the last 12 months and in characteristic locations (skinfolds, among others).
a Ofﬁcial ISAAC Center phase III.
b Chi-squared test: p < 0.001.
34  Solé  D  et  al.
Table  2  Percentage  of  variation  per  year  in  the  prevalence  of  asthma,  rhinitis  and  eczema  symptoms  in  adolescents  who
answered  the  International  Study  of  Asthma  and  Allergies  in  Childhood  (ISAAC)  written  questionnaire  in  centers  that  participated
in  ISAAC  phase  3  and  the  current  study.
Question  Belém  Recife  Maceió  Aracaju  Belo
Horizonte
São
Paulo
Curitiba General
Wheezing  at  some  time  -0.63  -0.54  -0.61  -0.98  -0.20  -0.10  -0.10  -0.41
Wheezing  last  year  -0.34  0.06  -0.23  -0.74  0.21  0.29  -0.14  -0.13
Speech  impairment 0.14 0.32  -0.21  -0.40  0.02  0.26  0.16  0.03
Asthma diagnosis -0.50 0.50 0.29  -0.34  0.83  0.33  0.43  0.41
Wheezing at  exercise -0.11 -0.06 -0.61 -0.33 0.34 -0.54  0.09  -0.14
Nocturnal  cough 0.11 0.41 -0.17 -0.38 0.21 1.34 0.86 0.60
Nasal symptoms  in  12  months  -0.46  -1.0  1.77  0.54  0.89  2.50  -0.84  0.68
Nasal and  ocular  symptoms  -0.09  0.31  0.71  -0.25  0.42  1.37  0.18  0.55
Skin symptoms  0.10  -0.19  0.20  -0.51  -0.09  -0.46  0.28  -0.06
Atopic  eczema  0.24  -0.12  0.16  -0.56  0.02  0.33  0.22  0.08
Speech impairment, wheezing so intense that was able to prevent two consecutive words from being said in the last 12 months; Wheezing
at exercise, wheezing during exercise in the past 12 months; Nocturnal cough, coughing at night without having a cold in the last 12
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months and in characteristic locations (skinfolds, among others).
In  December  of  2010,  the  rules  for  ﬁnancing  and  imple-
entation of  the  Basic  Component  of  Pharmaceutical  Care
ere approved,  providing  the  asthma  and  rhinitis  program
ith medications  from  the  National  Reference  List  of  the
asic Component  of  Pharmaceutical  Care.22 Certainly,  these
acts allowed  the  creation  of  care  programs  for  patients
ith asthma,  which  may  explain  the  increased  prevalence
f medical  diagnosis.  As  these  patients  have  access  to  treat-
ent, greater  control  of  the  disease  was  expected,  as
videnced by  a  reduction  in  the  frequency  of  severe  exacer-
ations, as  well  as  in  nonspeciﬁc  symptoms  observed  in  part
f the  Ads  included  in  the  present  study.  With  the  intro-
uction of  medical  guidelines  and  consensuses  on  asthma,
here was  a  greater  dissemination  of  knowledge  on  the  dis-
ase; thus,  the  term  ‘‘asthma’’  started  to  be  more  often
mployed by  physicians  and  patients,  replacing  euphemisms
uch as  bronchitis  and  tracheobronchitis.23 Another  conse-
uence was  the  asthma  treatment  standardization,  although
t is  not  always  fully  based  on  national  or  international23,24
uidelines.
Regarding rhinitis  and  rhinoconjunctivitis,  an  increase
n the  prevalence  of  both  was  observed  in  most  centers
nvolved in  the  study.  After  excluding  the  economic  fac-
or, another  component  that  could  be  involved  in  this
ncrease is  environmental  pollution.  A  previous  study  by  the
resent authors  (ISF3)  evaluated  the  association  between
he prevalence  of  asthma,  rhinitis,  and  eczema  and  levels
f photochemical  pollutants  in  Brazilian  centers  that  had
ir pollution  control  (Sao  Paulo,  Santo  André,  Curitiba,  and
orto Alegre).  Although  a  characteristic  pattern  between
he evaluated  symptoms  and  a  speciﬁc  air  pollutant  was
ot detected,  an  association  was  observed  between  greater
xposure to  photochemical  pollutants  and  high  prevalence
r risk  of  symptoms  of  asthma,  rhinitis,  and  atopic  eczema.25
f  the  centers  that  participated  in  this  study,  only  São  Paulo
nd Curitiba  have  had  air  pollutant  monitoring  since  the
SF3 was  performed,  which  allowed  for  the  observation,  in
oth centers,  of  an  improvement  of  air  quality  in  recent
ears.26--29 stufﬁness at some time in the last 12 months; Skin symptoms,
 eczema, itchy rash that appeared and disappeared in the last 12
In  conclusion,  the  present  study  found  that  the  preva-
ence of  active  asthma  has  possibly  reached  its  highest  level
nd has  stabilized.  Would  this  fact  be  due  to  the  reduction
n levels  of  air  pollution?  If  so,  how  can  the  increased  preva-
ence of  rhinitis,  rhinoconjunctivitis,  and  atopic  eczema
e explained?  Possible  explanations  for  these  ﬁndings  still
equire further  studies  that  are  targeted  for  these  primary
utcomes.
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